A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents

MLA

Odile Esther Levy, et al. “A Novel Long-Acting Glucose-Dependent Insulinotropic Peptide Analogue: Enhanced Efficacy in Normal and Diabetic Rodents.” Diabetes, Obesitymetabolism, vol. 16, no. 1, Apr. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....49bfabce2286df50f4cabf6756431cdf&authtype=sso&custid=ns315887.

APA

Odile Esther Levy, Soumitra S. Ghosh, B. R. Gedulin, Diane M. Hargrove, Ved Srivastava, Lala Mamedova, A. Lwin, S. Janssen, Julie A. Hoyt, David G. Parkes, L. Collins, Lawrence J. D’souza, Carolyn M. Jodka, Pamela A. Smith, & Krystyna Tatarkiewicz. (2013). A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents. Diabetes, Obesitymetabolism, 16(1).

Chicago

Odile Esther Levy, Soumitra S. Ghosh, B. R. Gedulin, Diane M. Hargrove, Ved Srivastava, Lala Mamedova, A. Lwin, et al. 2013. “A Novel Long-Acting Glucose-Dependent Insulinotropic Peptide Analogue: Enhanced Efficacy in Normal and Diabetic Rodents.” Diabetes, Obesitymetabolism 16 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....49bfabce2286df50f4cabf6756431cdf&authtype=sso&custid=ns315887.